Forte Biosciences (FBRX) Net Equity Issued and Repurchased (2016 - 2026)
Forte Biosciences (FBRX) reported Net Equity Issued and Repurchased of $149.9 million for Q2 2026.
Powered by 
Analysis
Forte Biosciences (FBRX) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Forte Biosciences' Net Equity Issued and Repurchased came in at $151.77 million; for FY2025, it came in at $1.78 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -51.6% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $14,000 in FY2024, $7.23 million in FY2022 and $62,000 in FY2021 (-99.9%).
- The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | 149.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.90 Mn |
| Mar 31, 2026 | 101,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 9,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Sep 30, 2023 | 24.79 Mn |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | -55,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 42.68 Mn |
| Jun 30, 2020 | 23.97 Mn |
| Mar 31, 2020 | 45,000.00 |
| Jun 30, 2019 | 4.61 Mn |
| Mar 31, 2019 | 248,000.00 |
| Dec 31, 2018 | 334,000.00 |
| Sep 30, 2018 | 3,000.00 |
API Access
Forte Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();